POET Technologies Shares Slide Monday: What's Going On? - POET Technologies (NASDAQ:POET)
The company sold 19,047,620 shares and warrants for US$400.0 million, while the stock fell 4.7% on Monday morning, Benzinga Pro said.
- On Monday, May 18, 2026, POET Technologies Inc. closed a registered direct offering, raising gross proceeds of US$400,000,020 from a single institutional investor.
- The agreed price of US$21.00 per security represented a premium over the NASDAQ Capital Market closing price of US$20.57 on Thursday, May 14, 2026.
- POET issued 19,047,620 common shares and equal warrants exercisable for three years at US$26.25, representing a 25% premium over the offering price.
- Following the announcement, POET shares fell 4.70% on Monday to US$15.23, according to Benzinga Pro data.
- Dr. Suresh Venkatesan, Chairman and Chief Executive Officer of POET, said the company is expanding capacity to support a "transition to higher volume manufacturing into 2027.
12 Articles
12 Articles
POET Stockholders Have Rights – If You Lost Money Investing in POET Technologies Inc. Contact ...
SAN DIEGO, May 18, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57…
Montreal Gazette
POET Technologies Announces Closing of US$400 Million Investment
Open the article to view the coverage from Montreal Gazette
POET lands $400m to ramp AI photonics production
POET Technologies has closed a US$400m investment round aimed at scaling manufacturing capacity and strengthening its position in photonic interconnects for AI infrastructure. The Toronto-based company, which develops photonic integrated circuits (PICs), optical engines and light-source products for hyperscale data centers and AI systems, said the funding came through a registered direct offering to a […] The post POET lands $400m to ramp AI pho…
POET Gets $400M Infusion But Shares Drop
POET Technologies closed a US$400 million direct investment with MMCAP International, issuing 19 million shares and warrants at $21 each. Shares fell 14.2% to $13.70 in heavy Nasdaq trading after opening higher. The funding follows a $50 million Lumilens order and a first-quarter net loss of $12.3 million. TSX Venture shares did not trade due to a Canadian holiday. The post POET Gets $400M Infusion But Shares Drop appeared first on TechStock².
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
